ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.

Quote:

Search for Ticker

Free Membership

Search:

CVS: Cvs Caremark Corporation - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

CVS CAREMARK CORPORATION (NYSE)
CVS	31.89	0.25	(0.79%)	Vol. 19,636,358	16:01 ET

CVS/Caremark is the nation's premier integrated pharmacy services provider, combining one of the nation's leading pharmaceutical services companies with the country's largest pharmacy chain. The company fills or manages more than one billion prescriptions per year, more than any other pharmacy services provider. CVS/Caremark drives value for pharmacy services customers by effectively managing pharmaceutical costs and improving healthcare outcomes through its six thousand two hundred CVS/pharmacy stores; its pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com.

General Information

CVS CAREMARK CP

One CVS Drive Woonsocket, RI 02895 Phone: 401-765-1500 Fax: 401-762-2137 Web: www.cvs.com Email: investorinfo@cvs.com

Industry	RETAIL-DRUG STR
Sector:	Retail/Wholesale

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/18/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	31.64
52 Week High	38.27
52 Week Low	23.74
Beta	0.79
20 Day Moving Average	27,440,282.00
Target Price Consensus	36.18

% Price Change
4 Week	-14.85
12 Week	-13.95
YTD	10.09

% Price Change Relative to S&P 500
4 Week	-15.77
12 Week	-18.88
YTD	-8.89

Share Information
Shares Outstanding (millions)	1,443.23
Market Capitalization (millions)	45,663.86
Short Ratio	1.43
Last Split Date	06/07/2005

Dividend Information
Dividend Yield	0.96%
Annual Dividend	$0.31
Payout Ratio	0.12
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	10/20/2009 / $0.08

EPS Information
Current Quarter EPS Consensus Estimate	0.78
Current Year EPS Consensus Estimate	2.62
Estimated Long-Term EPS Growth Rate	13.10
Next EPS Report Date	02/18/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.75
30 Days Ago	1.53
60 Days Ago	1.50
90 Days Ago	1.47

Fundamental Ratios

P/E
Current FY Estimate:	12.07
Trailing 12 Months:	12.41
PEG Ratio	0.92

EPS Growth
vs. Previous Year	8.33%
vs. Previous Quarter	0.00%

Sales Growth
vs. Previous Year	18.11%
vs. Previous Quarter:	-0.92%

Price Ratios
Price/Book	1.28
Price/Cash Flow	9.35
Price / Sales	0.47

ROE
09/30/09	10.54
06/30/09	10.53
03/31/09	10.57

ROA
09/30/09	6.10
06/30/09	6.15
03/31/09	6.20

Current Ratio
09/30/09	1.37
06/30/09	1.31
03/31/09	1.40

Quick Ratio
09/30/09	0.58
06/30/09	0.58
03/31/09	0.61

Operating Margin
09/30/09	3.84
06/30/09	3.93
03/31/09	4.02

Net Margin
09/30/09	5.90
06/30/09	6.05
03/31/09	6.18

Pre-Tax Margin
09/30/09	5.90
06/30/09	6.05
03/31/09	6.18

Book Value
09/30/09	24.72
06/30/09	24.83
03/31/09	24.21

Inventory Turnover
09/30/09	8.20
06/30/09	8.22
03/31/09	8.20

Debt-to-Equity
09/30/09	0.25
06/30/09	0.20
03/31/09	0.26

Debt to Capital
09/30/09	19.71
06/30/09	16.81
03/31/09	20.42


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research